BioCentury
ARTICLE | Clinical News

Immunocore preclinical data

May 14, 2012 7:00 AM UTC

In a mouse xenograft model of melanoma, 0.01 mg/kg ImmTAC-MAGE given every other day for 10 doses significantly inhibited tumor growth at day 22 through day 41 vs. vehicle-treated controls (p<0.001 fo...